CORZ Earnings & Financial Statements
Core Scientific, Inc.
$13.51
-$1.92(-12.44%)
36
Overall
40
Value
18
Tech
52
Quality
Market Cap
$4.34B
Volume
28.26M
52W Range
$13.36 - $30.46
Target Price
$32.73
CORZ earnings and financial statements: Core Scientific, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CORZ Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $319.02M | $510.67M | $502.40M | $640.31M | $544.48M |
| Cost of revenue | $281.12M | $389.60M | $378.94M | $631.91M | $50.16M |
| Operating income | -$245.59M | -$142.06M | $8.96M | -$2.11B | $131.49M |
| EBITDA | -$205.14M | -$1.28B | -$62.37M | -$1.83B | $97.81M |
| Net income | -$288.62M | -$1.44B | -$246.49M | -$2.15B | $47.31M |
| EPS (diluted) | $-0.88 | $-4.39 | $-0.65 | $-6.30 | $-0.83 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $2.35B | $1.48B | $712.16M | $807.69M | $2.44B |
| Total liabilities | $3.31B | $2.42B | $1.31B | $1.22B | $1.05B |
| Shareholders’ equity | -$962.74M | -$943.05M | -$596.94M | -$409.35M | $1.34B |
| Cash and equivalents | $311.38M | $836.20M | $50.41M | $15.88M | $117.87M |
| Long-term debt | $1.06B | $1.07B | $721.34M | $720.0K | $715.56M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $278.25M | $42.90M | $65.11M | $205.19M | -$56.73M |
| Capital expenditure | -$735.75M | -$95.19M | -$16.99M | -$601.66M | -$345.00M |
| Free cash flow | -$460.96M | -$52.30M | $48.12M | -$396.47M | -$56.73M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CORZ | $13.51 | -12.4% | 28.26M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |